Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with elevated intraocular pressure and paediatric glaucoma. L…
Category: News
Time is on Novartis Side in Alcon Bid
Novartiss bet that with time it would win over Alcon Inc.s shareholders seems to be paying off. Since the Swiss pharma giant bought a majority stake in the eye-care firm earlier this year, resistance from Alcons minority shareholders to Novartiss off…
Garamycin Ophthalmic Ointment Now Available from Fera Pharmaceuticals
Fera Pharmaceuticals announced the launch today of preservative free Garamycin (gentamicin sulfate) Ophthalmic Ointment USP. Providing an alternate gentamicin formulation, without preservatives, was an unmet need Fera was glad to fill. When Erythromy…
American Academy Of Ophthalmology Joint Meeting Marked By Academy Firsts And Strong Turnout
Academy firsts and strong turnout marked the largest and most comprehensive ophthalmic educational meeting in the world…
Contact Lenses: A Safe Option When Used Properly
For 40 million Americans, using contact lenses to improve vision is a way of life. While a good number adhere to the medical guidelines for wearing contacts, according to the American Optometric Association’s (AOA) annual American Eye-Q® survey, many …
Xalatan(R) Receives Paediatric Indication In Europe
Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with elevated intraocular pressure and paediatric glaucoma…
Drug Companies Influence Prescribing, Study Finds
Doctors tend to prescribe drugs that pharmaceutical companies promote to them and patients end up paying more but not always getting the most suitable medicines, researchers reported on Wednesday. Reuters Health Information
AAO Joint Meeting Marked by Academy Firsts and Strong Turnout
Academy firsts and strong turnout marked the largest and most comprehensive ophthalmic educational meeting in the world. The American Academy of Ophthalmologys (Academy) 2010 Joint Meeting in conjunction with the Middle East Africa Council of Ophthal…
AAO: Uveitis Tx Falls Short of Recommendations (CME/CE)
CHICAGO (MedPage Today) — Most ophthalmologists do not rely on evidence-based treatment guidelines for uveitis and, perhaps as a result, their practice patterns often deviated substantially from the recommendations, a survey showed.
New Clinical Data On Meriva Show Eye Inflammations Reduction
A new clinical study published in Clinical Ophthalmology shows that Meriva, an Indena proprietary complex of curcumin with soy phosphatidylcholine, can play an important role in the adjunctive therapy of recurrent anterior uveitis (RAU), the most com…
Novartis Third-Quarter Net Rises on Lucentis, Exforge
Novartis AG indicated Alcon Inc. shareholders should take another look at its $11.5 billion buyout offer now that an increase in the Swiss drugmakers share price and a rally in the franc have lifted the value of the bid. Novartis, which owns 77 perce…
Alcon 3Q profit falls on Novartis deal costs
Alcon Inc., which makes treatments for glaucoma and eye infections, said Wednesday its third-quarter net income fell 13 percent on costs related to its majority takeover by fellow Swiss drugmaker Novartis SA. Still the results topped analysts’ expect…
Abbott’s 3Q drug sales up 22 percent, net income drops on restructuring, recall costs
Abbott Laboratories, a maker of drugs and medical devices, fell after it reported third-quarter sales that missed analysts estimates. The shares dropped 45 cents, or less than 1 percent, to $52.42 at 4:03 p.m. in New York Stock Exchange composite tra…
AAO: Glaucoma Drug Passes Early Clinical Test (CME/CE)
CHICAGO (MedPage Today) — The first of a promising new class of glaucoma drugs reduced intraocular pressure and, perhaps more importantly, was additive with a current standard medication in a phase II trial, it was reported here.
New Clinical Data On Meriva(R) Show Eye Inflammations Reduction
A new clinical study published in Clinical Ophthalmology shows that Meriva®, an Indena proprietary complex of curcumin with soy phosphatidylcholine, can play an important role in the adjunctive therapy of recurrent anterior uveitis (RAU), the most com…
Miracle Of Sight: New Art Exhibit Shows The World Through Eyes That Were Once Blind
What if the blind could suddenly see? A unique art exhibit featuring photographs taken by people who were once blind but can now see because of a corneal transplant opens in Denver with a special preview on November 13 from 7 p.m. to 10 p.m. at the Net…
Many Georgians In The Dark When Protecting Their Eyes From The Sun
When it comes to working and playing in the great outdoors, many Americans know they should keep their skin protected from the sun; however, a new survey from Blue Cross and Blue Shield of Georgia (BCBSGa)’s parent company and Transitions Optical, Inc….
American Academy Of Ophthalmology-MEACO Joint Meeting 2010 Scientific Program Highlights
Results of clinical research on new presbyopia treatments now available in Europe – and possibly available soon in the United States – were reported in the Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and…
Researchers Discover Eye Test For Neurological Diseases In Livestock
The eyes of sheep infected with scrapie – a neurological disorder similar to mad cow disease – return an intense, almost-white glow when they’re hit with blue excitation light, according to a research project led by Iowa State University’s Jacob Petric…
A New Way Of Seeing The World
Scientists at The Montreal Neurological Institute and Hospital – The Neuro, McGill University have discovered that our brains have the ability to determine the shape of an object simply by processing specially-coded sounds, without any visual or tactil…